INDUSTRY NEWS | MyInVitroAnswer.com

top of page

Subscribe to Newsletter

Industry News

From new product launches and strategic partnerships to regulatory shifts, the in vitro economic and regulatory landscape is evolving rapidly.

This is where you'll step ahead on trends and identify new opportunities for your projects.

Scientific Illustrations The Art in Science

Children holding hands in a cercle. The center of the circle shows a human brain obtained through gene editing, illustrating gene therapy for human neurodevelopmental disorders.

Children holding hands in a cercle. The center of the circle shows a human brain obtained through gene editing, illustrating gene therapy for human neurodevelopmental disorders.

Muotri Lab's Pitt Hopkins syndrome patient-derived brain organoids lay the foundation for gene therapy trial

Hesperos' chronic inflammatory demyelinating polyneuropathy-on-chip instrumental to achieving orphan drug designation

Qureator's preclinical tumor model featured in world's first animal-free IND approval

2

Clinical Trial Authorizations

Product Launches

Taking off of an air balloon symbolizing the launching on the market of a new product. The bigger air balloon represents a multi-organ-on-a-chip whereas individual balloons represent a single-organ-on-a-chip system.

Taking off of an air balloon symbolizing the launching on the market of a new product. The bigger air balloon represents a multi-organ-on-a-chip whereas individual balloons represent a single-organ-on-a-chip system.

CN Bio launches its universal organ-on-a-chip platform PhysioMimix® Core to facilitate breakthroughs in drug discovery

Emulate launches Brain-Chip R1, first-in-class comprehensive neurovascular unit

Grants Awarded & Funds Raised

Axol Bioscience raises $2.8M to expand its human-based in vitro disease models

UMC Utrecht receives €2.3M grant to advance its generative, context-aware 3D bioprinting method

Hesperos awarded Phase IIB SBIR grant to investigate drug-induced cognitive impairment using its Human-on-a-Chip®

2 3

Pharma & Biotech Collaborations

Prellis Biologics joins forces with Eli Lilly to transform how target-specific human antibodies are generated

Illustration showing two paths that lead to an antibody, depicting converging pathways toward development of in vitro antibody generation platform.

Illustration showing two paths that lead to an antibody, depicting converging pathways toward development of in vitro antibody generation platform.

Heartbeat.bio partners with Boehringer Ingelheim to develop a gene therapy for cardiomyopathy

Mimetas partners with Attivare Therapeutics to accelerate innovation in cancer research

Intra-industry partnerships

A group of men and women helping each other climb a mountain, symbolizing collaboration across industries to build an alliance

A group of men and women helping each other climb a mountain, symbolizing collaboration across industries to build an alliance

Microphysiological systems pioneers launch Industry Alliance

Hesperos establishes strategic sales partnership with AsedaSciences to augment compound safety prediction

bottom of page